Continuous glucose monitoring systems for type 1 diabetes mellitus

Langendam, Miranda; Luijf, Yoeri M.; Hooft, Lotty; DeVries, J. Hans; Mudde, Aart N.; Scholten, R. J. P. M.

doi:10.1002/14651858.cd008101.pub2

Cited by 181 publications

(128 citation statements)

References 71 publications

Supporting

Mentioning

110

Contrasting

Unclassified

Order By: Relevance

“…[9][10][11][12] Similarly, continuous subcutaneous glucose sensing devices exist to improve blood glucose control, but again by a clinically unimportant amount. [13] It is gratifying that every one of our patients had access to a refrigerator. However, despite this some failed to store their insulin in the refrigerator, in an area where day temperatures are usually above 30°C in summer.…”

Section: Discussionmentioning

confidence: 95%

The poor children of the poor: Coping with diabetes control in a resource-poor setting

Villiers

2015

S Afr Med J

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 95%

The poor children of the poor: Coping with diabetes control in a resource-poor setting

Villiers

2015

S Afr Med J

View full text Add to dashboard Cite

“…Метаболические и психосоциальные • НМГ-РВ улучшает контроль гликемии (Класс I; Уровень А) [51][52][53][54][55].…”

Section: непрерывное мониторирование в режиме «реального времени»unclassified

“…• НМГ-РВ может влиять на показатели качества жизни [47,51,[56][57][58]. Во многих работах показано, что НМГ-РВ значительно повышает удовлетворен-ность лечением у пациентов с СД, а также у членов се-мей с больными СД детьми.…”

Section: непрерывное мониторирование в режиме «реального времени»unclassified

Russian national guidelines on insulin pump therapy and continuous glucose monitoring for diabetes mellitus patients. DRAFT

Shestakova

Владимировна²,

Mayorov

et al. 2015

Probl Endokrinol (Mosk)

View full text Add to dashboard Cite

Insulin pump therapy (continuous subcutaneous insulin infusion, CSII) and continuous glucose monitoring (CGM) are high-tech treatment and diagnostic tools for diabetes patients management which are actively used worldwide. CSII initiation and pump-users supervision became a part of routine clinical practice in Russia along with the CGM. Present project of clinical guidelines is based on international and domestic experience in CSII and CGM for diabetes treatment. Guidelines should ensure uniformity of CGM and CSII usage in Russia by health care professionals and diabetes patients and provide them an international experience to guarantee height performance of the technology. This article contains a preliminary version of the guidelines (draft) prepared for further expert’s discussion and review. The final version of the clinical guidelines will be sent to the Ministry of Health of the Russian Federation for approval.

show abstract

“…However, data from systematic reviews and meta-analysis on effectiveness of insulin pump therapy and continuous glucose monitoring have been mixed, particularly in the pediatric population [14–16]. Clinical benefits of continuous glucose monitoring including combined use of insulin pump are conditioned on high regular use [16,17]. Although insulin pump therapy and continuous glucose monitoring may be beneficial in terms of glycemic control, quality of life, and hypoglycemia [12], the majority of young people with type 1 diabetes still do not meet treatment targets especially among adolescents [18,19].…”

Section: Introductionmentioning

confidence: 99%

Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes

Tauschmann

Hovorka

2017

Expert Opinion on Drug Delivery

View full text Add to dashboard Cite

Introduction: Nocturnal glucose control remains challenging in children and adolescents with type 1 diabetes due to highly variable overnight insulin requirements. The issue may be addressed by glucose responsive insulin delivery based on real-time continuous glucose measurements.Areas covered: This review outlines recent developments of glucose responsive insulin delivery systems from a paediatric perspective. We cover threshold-based suspend application, predictive low glucose suspend, and more advanced single hormone and dual-hormone closed-loop systems. Approaches are evaluated in relation to nocturnal glucose control particularly during outpatient randomised controlled trials.Expert opinion: Significant progress translating research from controlled clinical centre settings to free-living unsupervised home studies have been achieved over the past decade. Nocturnal glycaemic control can be improved whilst reducing the risk of hypoglycaemia with closed-loop systems. Following the US regulatory approval of the first hybrid closed-loop system in non-paediatric population, large multinational closed-loop clinical trials and pivotal studies including paediatric populations are underway or in preparation to facilitate the use of closed-loop systems in clinical practice.

show abstract

Continuous glucose monitoring systems for type 1 diabetes mellitus

Abstract: Continuous glucose monitoring systems for type 1 diabetes mellitus.

Cited by 181 publications

References 71 publications

The poor children of the poor: Coping with diabetes control in a resource-poor setting

The poor children of the poor: Coping with diabetes control in a resource-poor setting

Russian national guidelines on insulin pump therapy and continuous glucose monitoring for diabetes mellitus patients. DRAFT

Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes

Contact Info

Product

Resources

About